Liminatus Pharma, Inc. - LIMN
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$189K
QoQ value delta ($000)
-$245K
(-56.45%)
Implied price effect (QoQ)
-64.04%
Shares
Total shares
317,193
QoQ shares delta
+55,269
(+21.1%)
Total shares held by funds (by quarter)
Market chart (LIMN)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 44 | 73,424 | 0.0% |
| CITADEL ADVISORS LLC | 43 | 70,930 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 39 | 65,051 | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 21 | 35,284 | 0.0% |
| STATE STREET CORP | 11 | 19,000 | 0.0% |
| UBS Group AG | 11 | 19,395 | 0.0% |
| BlackRock, Inc. | 8 | 13,255 | 0.0% |
| TWO SIGMA SECURITIES, LLC | 7 | 11,875 | 0.0% |
| Tower Research Capital LLC (TRC) | 5 | 8,903 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 44 | 0.0% |
| CITIGROUP INC | 0 | 1 | 0.0% |
| Farther Finance Advisors, LLC | 0 | 31 | 0.0% |